Estrella Immunopharma, Inc. Liquidation Value
ESLA
Other
Cash & Equivalents
$1.38M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $1.38M
Total Obligations: -$13.54M
$-12.16M
Per share: $-0.32
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $1.38M
AR: $0
Total Obligations: -$13.54M
$-12.16M
Per share: $-0.32
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $1.38M
AR: $0
Inventory: $0
Total Obligations: -$13.54M
$-12.16M
Per share: $-0.32
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-12.16M | $-0.32 |
| Liquid Liquidation Value | $-12.16M | $-0.32 |
| Operating Liquidation Value | $-12.16M | $-0.32 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $1.38M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $13.54M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 37.8M |
Explore all 109 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.38M | N/A | N/A | N/A | $13.54M | N/A | N/A | N/A |
| 2025-09-30 | $1.63M | N/A | N/A | N/A | $13.36M | N/A | N/A | N/A |
| 2025-06-30 | $1.32M | N/A | N/A | N/A | $9.08M | N/A | N/A | N/A |
| 2025-03-31 | $421,473 | N/A | N/A | N/A | $4.28M | N/A | N/A | N/A |
| 2024-12-31 | $916,916 | N/A | N/A | N/A | $3.00M | N/A | N/A | N/A |
| 2024-09-30 | $1.80M | N/A | N/A | N/A | $2.99M | N/A | N/A | N/A |
| 2024-06-30 | $4.17M | N/A | N/A | N/A | $180,701 | N/A | N/A | N/A |
| 2024-03-31 | $4.73M | N/A | N/A | N/A | $138,491 | N/A | N/A | N/A |
▼ Community Notes